Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated March 31, 2025, titled "Press Release about submission of IND Application for SBO-154 to USFDA".
Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated March 31, 2025, titled "Press Release about submission of IND Application for SBO-154 to USFDA".